1Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action offibrateson lipid and lipoprotein metabolism[J]. Circulation, 1998, 98 (19) : 2088. 被引量：1
2Playford DA, Watts GF, Best JD, el al. Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus[J]. Am J Cardiol, 2002,90(11) : 1254. 被引量：1
3Ogata T, Miyauchi T,Irukayarrka-Tomobe Y, et al. The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin- 1-induced cardiac fibroblast proliferation[ J]. J Cantiovasc Pharmacol, 2004,44(Suppl 1 ) : $279. 被引量：1
4Zambon A, Gervois P, Pauletto P, et al. Modulation of hepatic inflamnkatory risk markers of cardiovascular diseases by PPARa activators: clinical and experimental evidence [ J ]. Arterioscler Thromb Vase Biol, .2006, 26(5):977. 被引量：1
6Kim J, Aim JH, Kim JH, et al. Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway[J]. Exp Eye Res, 2007, 84(5):886. 被引量：1
7Chanda D, Lee CH, Kim YH, et al. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate activated protein kinase dependent induction of orphan nuclear receptor small hetert-timer partner [ J ]. Hepatology, 50 ( 3 ) :880. 被引量：1
8Murakami H, Murakanti R, Kambe F, et al. Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC[J]. Biochem Biophys Res Commun, 2006, 341 (4) : 973. 被引量：1
9Genest J, Froblich J, Steinvr G, etal. Effect of fenofibrate-mediated increase in plasma homceysteine on the progression of coronary artery disease in type 2 diabetes mellitus[J] .Am J Cardio,2004, 93(7):848. 被引量：1
10Davidson MH, Jones PH. Retrospective eomparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet[J]. Clin Drug Invest, 2008, 28(10) :615. 被引量：1
8Keating GM,Croom KF.Fenofibrate:A review of its use in primary dyslipidaemia,the metabolic syndrome and type 2 diabetes mellitus[J].Drugs,2007,67(1):121-153. 被引量：1
9Fournier Innovation et Synergie.Novel dosage form of fenofibrate[P].US:4895726,1990-01-23. 被引量：1
10Guichard JP,Blouquin P,Qing Y.A new formulation of fenofibrate:Suprabioavailable tablets[J].Current Medical Research and Opinion,2000,16(2):134-138. 被引量：1
